A carregar...
Cilengitide: A Prototypic Integrin Inhibitor for the Treatment of Glioblastoma and Other Malignancies
Integrins are critical intermediaries in a wide spectrum of cancer cell activities and thus represent a highly attractive target in oncology therapy. Nonetheless, successful exploitation of anti-integrin therapeutics has proven challenging to date for cancer patients. In this review, we will focus o...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3411133/ https://ncbi.nlm.nih.gov/pubmed/22866207 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1947601912450586 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|